Clinical Trials Sponsored by National Institute for Cancer Research, Italy

Total 5496 results

Cancer Prevention and Research Institute, Italy

Unknown

Innovation in Mammography: Tomosynthesis Pathways (IMPETO)

Breast Cancer

Italy
Cancer Prevention and Research Institute, Italy
Ministry of Health, Italy

Unknown

Tailored Screening for Breast Cancer in Premenopausal Women (TBST)

Breast Cancer

Italy
Cancer Prevention and Research Institute, Italy
Istituto Toscano Tumori

Unknown

Self Collected Sampling in Non-attendees Cervical Cancer Screening: DNA Test and Molecular Triage for HPV Positive Women

Cervical Cancer

Italy
Ludwig Institute for Cancer Research
National Cancer Institute (NCI)

Terminated

Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer

Ovarian Cancer

United States
Ludwig Institute for Cancer Research
National Cancer Institute (NCI)

Completed

Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer

Colorectal Neoplasms

Australia
Ludwig Institute for Cancer Research
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Ludwig Institute for Cancer Research
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer

Kidney Cancer

United States
Ludwig Institute for Cancer Research
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas

Transitional Cell Carcinoma

United States
Ludwig Institute for Cancer Research
National Cancer Institute (NCI)

Completed

Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer

Ovarian Cancer

United States
Ludwig Institute for Cancer Research
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC)

Lung Cancer

United States
Mario Negri Institute for Pharmacological Research
Bio3 Research s.r.l. - Milan Italy

Completed

L-Cysteine in Peritoneal Dialysis (CINDY)

Uremia

Italy
Catholic University, Italy
Italian Research Group For Gastric Cancer - IRGGC

Completed

Gastric Decompression After Sub-total Gastrectomy

Gastric Cancer

Italy
Mario Negri Institute for Pharmacological Research
Otsuka Pharmaceutical Italy S.r.l.

Completed

Tolvaptan-Octreotide LAR Combination in ADPKD (TOOL)

Autosomal Dominant Polycystic Kidney Disease

Italy
Mario Negri Institute for Pharmacological Research
Alexion Pharma Italy s.r.l.

Completed

Eculizumab in Primary MPGN (EAGLE)

Membranoproliferative Glomerulonephritis

Italy
Cancer Prevention and Research Institute, Italy
Veneto Tumor Registry, Azienda Zero, Padua, Italy

Unknown

Adenoma Detection Rate With Endocuff-Assisted Colonoscopy - an Italian Trial (ITAvision)

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma | Colorectal Polyp

Italy
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Gateway for Cancer Research

Active, not recruiting

Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment

Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Gateway for Cancer Research

Active, not recruiting

TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Primary Peritoneal Cancer | Fallopian Tube | Epithelial Ovarian

United States
Cancer Prevention and Research Institute, Italy
University of Florence

Completed

Screening for Colorectal Cancer With FOBT, Virtual Colonoscopy and Optical Colonoscopy. A Randomized Clinical Trial in the Florence District (SAVE)

Colorectal Cancer

Italy
Center for Outcomes Research and Clinical Epidemiology...
Artsana S.p.a.

Unknown

Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. (AGO 02)

Diabetes Mellitus

Italy
Ludwig Institute for Cancer Research
Cancer Research Institute (CRI)

Completed

NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)

Malignant Melanoma

United States
Ludwig Institute for Cancer Research

Terminated

Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer

Colorectal Cancer

United States
American Institute for Cancer Research

Completed

Testing the Effectiveness of Coping With Cancer in the Kitchen (CCK)

Cancer | Nutrition Aspect of Cancer

United States
Ludwig Institute for Cancer Research

Completed

111In-ch806 in Patients With Advanced Tumours Expressing the 806 Antigen

Neoplasms

Australia
Ludwig Institute for Cancer Research

Terminated

Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma

Malignant Melanoma

Belgium
Ludwig Institute for Cancer Research

Completed

A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.

Cancer | Neoplasm

Germany
Ludwig Institute for Cancer Research

Terminated

Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma

Malignant Melanoma

Belgium
Ludwig Institute for Cancer Research

Completed

Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1

Neoplasms

Japan
National Center for Research Resources (NCRR)
Children's National Research Institute

Completed

A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)

Muscular Dystrophy, Duchenne

United States
Ludwig Institute for Cancer Research

Completed

Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer

Prostate Cancer

Switzerland, Germany
Ludwig Institute for Cancer Research

Completed

Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

Switzerland, Germany
Southern Italy Cooperative Oncology Group

Unknown

Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Colorectal Cancer

Italy
National Research Center for Hematology, Russia
National Research Center for Hematology

Recruiting

R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis

Diffuse Large B-Cell Lymphoma

Russian Federation
Cancer Prevention and Research Institute, Italy
University of Florence; Istituto Toscano Tumori

Completed

Effect of HPV Vaccination on Women Aged 25 Years

Cervical Cancer

Italy
Emory University
National Cancer Institute (NCI); Gateway for Cancer Research

Recruiting

Personalized Autologous Transplant for Multiple Myeloma

Multiple Myeloma

United States
Northwestern University
National Cancer Institute (NCI); Gateway for Cancer Research

Terminated

Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission

Stage III Diffuse Large B-Cell Lymphoma | Stage IV Diffuse Large B-Cell Lymphoma

United States
Villa Beretta Rehabilitation Center
National Research Council of Italy

Completed

Rehabilitation Multi Sensory Room for Robot Assisted Functional Movements in Upper-limb Rehabilitation in Chronic Stroke (RehaMSR)

Chronic Stroke

Italy
Mario Negri Institute for Pharmacological Research
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; Humanitas Hospital,...

Recruiting

Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. (TRABEPIO)

Liposarcoma, Myxoid | Liposarcoma, Dedifferentiated | Liposarcoma, Round Cell

Italy
Ludwig Institute for Cancer Research
Cancer Research Institute, NY, USA

Terminated

NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma

Unresectable or Metastatic Melanoma

United States, Australia
National Cancer Institute, Naples
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab (MITO16/MANGO-2)

Ovarian Cancer

Italy
National Cancer Institute, Naples
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer (MITO16MANGO2b)

Recurrent Ovarian Cancer

France, Italy, Switzerland, Monaco, Greece
National Cancer Institute, Naples
Mario Negri Institute for Pharmacological Research

Recruiting

Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer (MITO28MaNGOov4)

Ovarian Cancer

Italy
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Alaunos Therapeutics; National Center for Research...

Recruiting

Long-Term Follow-Up of Recipient of Gene Transfer Research

Retroviridae Infections | Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Foundation for Women's Cancers

Recruiting

Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women

Breast Carcinoma

United States
Institute of Cancer Research, United Kingdom
Cancer Research UK; National Institute for Health Research, United Kingdom

Recruiting

The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a BRCA Gene Mutation. (GENPET)

Prostate Cancer | BRCA1 Mutation | BRCA2 Mutation

United Kingdom
Institute of Cancer Research, United Kingdom
Cancer Research UK; National Institute for Health Research, United Kingdom

Completed

Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome (SIGNIFY)

Li-Fraumeni Syndrome

United Kingdom
Scottsdale Healthcare
Translational Genomics Research Institute; National Foundation for Cancer Research

Completed

An Ancillary Pilot Trial Using Whole Genome Sequencing In Patients With Advance Refractory Cancer

Advanced Cancer

United States
Ottawa Hospital Research Institute
Ontario Institute for Cancer Research

Not yet recruiting

PD-1 +/- IL-4 Inhibition in ER+ Breast Cancer

Breast Cancer

Canada
Lawson Health Research Institute
Ontario Institute for Cancer Research

Completed

Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer

Head and Neck Cancer | Radiation-Induced Mucositis

Canada
Lawson Health Research Institute
Ontario Institute for Cancer Research

Active, not recruiting

ARREST - A Phase I Study of SABR for Poly-metastatic Disease

Metastatic Cancer

Canada
Lawson Health Research Institute
Ontario Institute for Cancer Research

Completed

Advanced Prostate Imaging of Recurrent Cancer After Radiotherapy (PICs)

Prostate Cancer

Canada

Clinical Trials Sponsored by National Institute for Cancer Research, Italy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations